相关实验视频

Updated: Jun 11, 2025

Bio-layer Interferometry for Measuring Kinetics of Protein-protein Interactions and Allosteric Ligand Effects

Bio-layer Interferometry for Measuring Kinetics of Protein-protein Interactions and Allosteric Ligand Effects

Published on: February 18, 2014

使用分子对接,分子动力学和表面等离子体共振分析,阐明β-固醇和lyszyme之间的结合相互作用

Tuba Kuşman Sayğı¹, Evren Gazel Pınar², Ilgaz Taştekil^3,4

¹Medicinal and Aromatic Plants Program, Hamidiye Vocational School of Health Services, University of Health Sciences Turkey, 34668, İstanbul, Türkiye.

Chemistry & biodiversity

|October 7, 2024

概括

这项研究揭示了β-固醇与lyszyme结合,计算和SPR方法显示了显著的相互作用. 这些发现为营养和制药应用提供了洞察力.

科学领域:

生物化学生物化学
分子生物学分子生物学
药理学药理学是指药理学的学科.

背景情况:

酶是先天免疫的关键酶,在各种行业中都有应用.
了解蛋白质-连接体相互作用对于药物发现和营养科学至关重要.

研究的目的:

阐明β-固醇与酶 (LZM) 的结合行为.
为了确定β-sitosterol和蛋白溶酶 (CEWL) 之间的结合亲和力和关键相互作用残留物.

主要方法:

表面等离子共振 (SPR) 光谱.表面等离子共振 (SPR) 光谱.
计算分子对接和分子动力学模拟.
对于具有约束力的能源贡献的MMPBSA分析.

主要成果:

与NAG3.3相比,β-sitosterol表现出有利的结合能量 (-6.68±0.04 kcal/mol) 与NAG3.4相比,β-sitosterol表现出有利的结合能量 (-6.68±0.04 kcal/mol).
在SPR分析中,β-醇-CEWL结合的解离常数 (KD) 为71.34±9.79μM.
关键残留物 (Glu35, Gln57-Asn59, Trp62, Ile98, Ala107, Trp108) 被确定为关键的结合.

结论:

β-固醇有效地与酶结合,表明潜在的治疗或营养作用.
这项研究提供了对β-醇-酶相互作用的分子层面的理解.
这些发现与营养,制药科学和口腔生物学方面的进展有关.

关键词:

莱索酶是什么莱索酶是什么分子对接是分子对接.分子动力学模拟模型表面等离子体共振是什么?这是一种β-sitosterol.

更多相关视频

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Published on: May 9, 2025

Identifying PD-1/PD-L1 Inhibitors with Surface Plasmon Resonance Technology

Identifying PD-1/PD-L1 Inhibitors with Surface Plasmon Resonance Technology

Published on: May 2, 2025

相关概念视频

Ligand Binding Sites

Ligand Binding Sites

Proteins are dynamic macromolecules that carry out a wide variety of essential processes; however, the activities of most proteins depend on their interactions with other molecules or ions, known as ligands.
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...

The Equilibrium Binding Constant and Binding Strength

The Equilibrium Binding Constant and Binding Strength

The equilibrium binding constant (Kb) quantifies the strength of a protein-ligand interaction. Kb can be calculated as follows when the reaction is at equilibrium:

Ligand Binding and Linkage

Ligand Binding and Linkage

Allosteric proteins have more than one ligand binding site; the binding of a ligand to any of these sites influences the binding of ligands to the other sites. When a protein is allosteric, its binding sites are called coupled or linked. In the case of enzymes, the site that binds to the substrate is known as the active site and the other site is known as the regulatory site. When a ligand binds to the regulatory site, this leads to conformational changes in the protein that can influence...

Protein-Drug Binding: Determination Methods

Protein-Drug Binding: Determination Methods

Determining protein-drug binding can be achieved through indirect and direct methods, each providing valuable insights into the interaction between proteins and drugs.
Indirect methods involve isolating the bound drug from its free form in biological samples such as blood, serum, or plasma. These techniques aim to measure the percentage of drugs bound to proteins. Equilibrium dialysis is a commonly used method where the free drug concentration at equilibrium is measured by separating the bound...